BT
Bicycle Therapeutics Ltd
🇩🇪XSTU.50BAGermanyHealthcare
€3.16EURdown -0.16 (-4.82%)OpenEnd of day6:07 PM
Price€3.16-0.16 (-4.82%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US0887861088
- CUSIP
- Not reported
Company
- Employees
- 288
- Headquarters
- Cambridge, United States
- CEO
- Dr. Kevin Lee M.B.A., Ph.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Key dates
- Next earnings
- Oct 29, 2026
Highlights
- Market cap
- Not reported
- EPS LTM
- -$2.73
- P/E LTM
- -1.57
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $61.21M+217.44%up year on year
- Net income
- -$190.41M+21.43%up year on year
- Gross margin
- 42.72%+103.91%up year on year
- Free cash flow
- -$205.59M+2.39%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.